Leerink Swann Downgrades United Therapeutics Corp. (UTHR) to Market Perform; Generic Risk
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $499.73 -0.31%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Swann downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Outperform to Market Perform, price target cut from $65 to $48.
Analyst, Joseph P. Schwartz, said, "Based on our analysis and feedback from MEDACorp patent specialists and a MEDACorp PAH survey, we see a less favorable risk/reward for UTHR shares at this juncture and valuation."
"Overall, most physicians believe that a minority of their patients are candidates for oral Remodulin. The most common view is that 20% of PAH pts. are candidates, according to 34% of physicians, followed by 10% of pts, according to 20% of physicians."
FY13 EPS estimate cut from $2.96 to $2.78. FY13 revs lowered from $965.5 mln to $947.5 mln.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $43.73 yesterday.
Analyst, Joseph P. Schwartz, said, "Based on our analysis and feedback from MEDACorp patent specialists and a MEDACorp PAH survey, we see a less favorable risk/reward for UTHR shares at this juncture and valuation."
"Overall, most physicians believe that a minority of their patients are candidates for oral Remodulin. The most common view is that 20% of PAH pts. are candidates, according to 34% of physicians, followed by 10% of pts, according to 20% of physicians."
FY13 EPS estimate cut from $2.96 to $2.78. FY13 revs lowered from $965.5 mln to $947.5 mln.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $43.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
